Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates

This publication has 14 references indexed in Scilit:

• Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
  The Pediatric Infectious Disease Journal, 2009
• Molecular Epidemiology of A/H3N2 and A/H1N1 Influenza Virus during a Single Epidemic Season in the United States
  PLoS Pathogens, 2008
• Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
  Vaccine, 2008
• Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria
  Vaccine, 2007
• Response of Influenza Vaccines Against Heterovariant Influenza Virus Strains in Adults with Chronic Diseases
  Journal of Clinical Immunology, 2007
• An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine
  Vaccine, 2006
• Quantifying influenza vaccine efficacy and antigenic distance
  Vaccine, 2006
• Antigenic characterisation of influenza B virus with A new microneutralisation assay: Comparison to haemagglutination and sequence analysis
  Journal of Medical Virology, 2004
• Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
  Virus Research, 2004
• The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
  Vaccine, 2001